Immune‐related dermatitis during combined treatment with pembrolizumab and axitinib in a patient with metastatic renal cell\x92carcinoma with stasis dermatitis
Shunsuke Imai(RIKEN Center for Integrative Medical Sciences), Yoshiyuki Shiga(NTT Medical Center), Ryousuke Ooki(NTT Medical Center), Satomi Chujo(NTT Medical Center), Atsuyuki Igarashi(NTT Medical Center), Masaki Nakamura(NTT Medical Center), Yasushi Inoue(NTT Medical Center), Hajime Horiuchi(NTT Medical Center), Keita Uchino(NTT Medical Center), Teppei Morikawa(Dana-Farber Cancer Institute)
Cited by 2
Related Papers
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
|Nature|2012|1.7k
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
|New England Journal of Medicine|2013|1.5k
Aspirin Use, Tumor<i>PIK3CA</i>Mutation, and Colorectal-Cancer Survival
|New England Journal of Medicine|2012|845
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
|Cancer Discovery|2018|558